Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

STRATA Skin Sciences (SSKN) Shares Issued (2010 - 2025)

STRATA Skin Sciences recorded quarterly Shares Issued of $2.2 million in Q3 2025, down 5.82% quarter-over-quarter from $2.3 million in Q4 2018.

STRATA Skin Sciences' Shares Issued history runs 6 years deep, the most recent figure standing at $2.2 million for Q3 2025.

  • In Q3 2025, Shares Issued changed N/A year-over-year to $2.2 million; the TTM figure through Sep 2025 stood at $2.2 million (changed N/A YoY), while the FY2025 annual figure was $3.6 million, up 84.2% from the prior year.
  • Shares Issued came in at $2.2 million for Q3 2025 at STRATA Skin Sciences, down from $2.3 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $2.2 million in Q3 2025 to a low of $2.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 116.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 164.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 81.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 68.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 12.70 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 STRATA Skin Sciences - - 5.61 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 2.20 Mn
Sep 30, 2025 2.20 Mn
Dec 31, 2018 2.34 Mn
Dec 31, 2018 2.34 Mn
Jun 30, 2018 14.66 Mn
Jun 30, 2018 14.66 Mn
Sep 30, 2014 5,493.00
Sep 30, 2014 5,493.00
Jun 30, 2014 -8,208.00
Jun 30, 2014 -8,208.00
Mar 31, 2014 11.46 Mn
Mar 31, 2014 11.46 Mn
Dec 31, 2013 -15.77 Mn
Dec 31, 2013 -15.77 Mn
Jun 30, 2013 15.77 Mn
Jun 30, 2013 15.77 Mn
Mar 31, 2013 18,059.00
Mar 31, 2013 18,059.00
Dec 31, 2012 -3.05 Mn
Dec 31, 2012 -3.05 Mn
Sep 30, 2012 3.06 Mn
Sep 30, 2012 3.06 Mn
Mar 31, 2012 33,310.00
Mar 31, 2012 33,310.00
Dec 31, 2010 15.21 Mn
Dec 31, 2010 15.21 Mn